The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu ...

The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...

The study included vaccine candidates against H5 and H7 avian influenza viruses. Based on the positive preliminary data from the Phase 1/2 study, Moderna is preparing to advance mRNA-1018 into ...